Computed Tomography
Diagnostic Testnoncontrast-enhanced chest computed tomography
NCT Number: NCT03581110
The noncontrast-enhanced chest computed tomography (CT) is an emerging diagnostical tool in patient with chronic obstructive pulmonary disease (COPD). As shown in previous studies and pointed out by the Fleischner society, an additional scan in expiration reflects the pathophysiology of this complex disease better and extends the clinical information of the CT.
Nevertheless, this scan is leading to an increase in radiation dose. But currently it is unclear if this increased radiation dose is proportional to the additional clinical value when compared to inspiration-only protocols. Therefore, the aim of this study was to compare the organ specific radiation doses of a combined inspiration-expiration CT on a 3rd generation dual-source scanner with noncontrast-enhanced chest CTs of two clinical routine scanners. Therefore, the radiation doses of nearly 2000 chest CTs have been evaluated.
Looking for future studies?
Notify MeAll sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
noncontrast-enhanced chest computed tomography
Time frame: The organ dose calculations have been performed retrospectively. Therefore, the time frame is variable. The time set for the final outcome calculations was September 2017. Therefore, the time frame varies between 3 years and 1 week.
Organ specific radiation doses of 17 individual organs
Universitätsmedizin Mannheim
Other
CODP Imaging From a Dose Perspective - Effective Organ Doses of a Combined Inspiration-expiration Protocol on a 3rd Generation Dual-source CT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07043790
Cystectomy, Radiation
Cairo, Egypt
View Trial DetailsNCT03461341
Chemoradiation, Chemotherapy
Dublin, Ireland
View Trial DetailsNCT03735706
Body Weight, Contrast Media
Maastricht, Limburg, Netherlands
View Trial DetailsNCT03235427
Adenocarcinoma, Arterial Occlusive Diseases
Lake Success, New York, United States
View Trial Details